LBPH
Price:
$59.8
Market Cap:
$2.33B
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.[Read more]
Industry
Biotechnology
IPO Date
2021-03-12
Stock Exchange
NASDAQ
Ticker
LBPH
According to Longboard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.97. This represents a change of -13.09% compared to the average of 18.37 of the last 4 quarters.
The mean historical Current Ratio of Longboard Pharmaceuticals, Inc. over the last ten years is 12.67. The current 15.97 Current Ratio has changed 12.50% with respect to the historical average. Over the past ten years (40 quarters), LBPH's Current Ratio was at its highest in in the June 2021 quarter at 36.87. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
12.67
Median
12.81
Minimum
5.14
Maximum
19.91
Discovering the peaks and valleys of Longboard Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.74%
Maximum Annual Current Ratio = 19.91
Minimum Annual Increase = -59.97%
Minimum Annual Current Ratio = 5.14
Year | Current Ratio | Change |
---|---|---|
2023 | 5.14 | -35.52% |
2022 | 7.97 | -59.97% |
2021 | 19.91 | 12.74% |
The current Current Ratio of Longboard Pharmaceuticals, Inc. (LBPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.01
5-year avg
12.67
10-year avg
12.67
Longboard Pharmaceuticals, Inc.’s Current Ratio is greater than Molecular Partners AG (14.33), less than MediciNova, Inc. (16.66), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), greater than Werewolf Therapeutics, Inc. (10.10), less than Edgewise Therapeutics, Inc. (26.35), greater than Decibel Therapeutics, Inc. (4.81), greater than Celcuity Inc. (10.36), greater than C4 Therapeutics, Inc. (6.31), greater than Assembly Biosciences, Inc. (2.36), greater than NextCure, Inc. (9.07), greater than Nuvation Bio Inc. (9.57), greater than Graphite Bio, Inc. (11.47), greater than Instil Bio, Inc. (12.90), greater than Sensei Biotherapeutics, Inc. (8.84), greater than Merrimack Pharmaceuticals, Inc. (10.78), greater than Monte Rosa Therapeutics, Inc. (6.03), less than Design Therapeutics, Inc. (34.61), greater than Ikena Oncology, Inc. (15.32), greater than Stoke Therapeutics, Inc. (5.09),
Company | Current Ratio | Market cap |
---|---|---|
14.33 | $216.81M | |
16.66 | $104.47M | |
3.45 | $37.86M | |
0.69 | $61.85M | |
21.89 | $108.71M | |
10.10 | $84.67M | |
26.35 | $3.05B | |
4.81 | $123.37M | |
10.36 | $489.74M | |
6.31 | $300.00M | |
2.36 | $95.60M | |
9.07 | $33.33M | |
9.57 | $942.39M | |
11.47 | $185.19M | |
12.90 | $170.65M | |
8.84 | $13.11M | |
10.78 | $223.97M | |
6.03 | $521.60M | |
34.61 | $318.21M | |
15.32 | $82.52M | |
5.09 | $605.41M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longboard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Longboard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Longboard Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Longboard Pharmaceuticals, Inc. (LBPH)?
What is the highest Current Ratio for Longboard Pharmaceuticals, Inc. (LBPH)?
What is the 3-year average Current Ratio for Longboard Pharmaceuticals, Inc. (LBPH)?
What is the 5-year average Current Ratio for Longboard Pharmaceuticals, Inc. (LBPH)?
How does the current Current Ratio for Longboard Pharmaceuticals, Inc. (LBPH) compare to its historical average?